Cargando…
IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
Isocitrate dehydrogenase 1 (IDH1) is the most frequently mutated gene in World Health Organization grade II–III and secondary glioma. The majority of IDH1 mutation cases involve the substitution from arginine to histidine at codon 132 (IDH1-R132H). Although the oncogenic role of IDH1-R132H has been...
Autores principales: | Yin, Narui, Xie, Ting, Zhang, Haowen, Chen, Jian, Yu, Jiahua, Liu, Fenju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956398/ https://www.ncbi.nlm.nih.gov/pubmed/31966064 http://dx.doi.org/10.3892/ol.2019.11148 |
Ejemplares similares
-
TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport
por: Zhang, Yushuo, et al.
Publicado: (2017) -
IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014) -
IDH1(R132H) decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a
por: NIE, QUAN-MIN, et al.
Publicado: (2015) -
In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
por: Borhani, Samira, et al.
Publicado: (2017) -
The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells
por: Liu, Ping, et al.
Publicado: (2018)